Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
4
×
boston blog main
boston top stories
crispr
crispr therapeutics
editas medicine
san francisco blog main
san francisco top stories
biotech
boston
cancer
crispr-cas9
deals
feng zhang
gene editing
intellia therapeutics
national
acquisitions
advanced therapies
agios therapeutics
atmp
avexis
base editing
bioprocess insider
bms
brammer bio
branden moriarty
bristol-myers squibb
broad institute
car-t
car-t chimeric antigen receptor
cas13
catalent
cell & gene
cell gene therapy
cell therapeutics
cell therapies
clinical trials
What
crispr
4
×
gene
4
×
editing
cas
human
medicine
therapeutics
access
advanced
beam
bio
cancer
capacity
car
cell
cells
consolidation
create
defect
diagnostic
diseases
drive
editas
edited
editor
falcon
fears
fix
flag
focus
founders
genetic
gotten
guardian
harvard
heats
high
jump
known
lab
Language
unset
Current search:
gene
×
" national top stories "
×
crispr
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M